Clinical Trials Directory

Trials / Terminated

TerminatedNCT00733369

A Study to Compare the Press Fit Condylar (P.F.C.) Sigma Rotating-platform High-flexion (RP-F) Versus the Press Fit Condylar (P.F.C.) Sigma Rotating-platform (RP) Knee Implants

A Prospective, Single Blinded, Multi-centre Randomised Controlled Trial Comparing the Post Operative Range of Motion of the P.F.C. Sigma RP-F Knee With the P.F.C. Sigma RP Knee in Primary Total Knee Arthroplasty.

Status
Terminated
Phase
Phase 4
Study type
Interventional
Enrollment
106 (actual)
Sponsor
DePuy International · Industry
Sex
All
Age
45 Years – 75 Years
Healthy volunteers
Not accepted

Summary

The main objective of this study is to determine if the P.F.C. Sigma RP-F Knee delivers a greater post-operative range of motion (ROM) compared with the P.F.C. Sigma RP Knee in primary TKA. The secondary objectives of this investigation are to evaluate the clinical and patient outcomes and survivorship associated with the DePuy P.F.C. Sigma RP-F and RP Posterior Stabilised (PS) Knee over 5 years.

Detailed description

Primary Outcome: Change from pre-operative range of motion at 1 year between patients receiving P.F.C. Sigma RP vs P.F.C. Sigma RP-F Secondary endpoints: Comparative evaluation of any post-operative variation between subjects receiving primary TKA with either of the above devices in terms of Knee and Osteoarthritis Scores (KOOS), American Knee Society Score (AKS), EQ-5D Score and Oxford Knee Score (OKS)

Conditions

Interventions

TypeNameDescription
DEVICEPFC Sigma RP-FAn orthopaedic implant for total knee replacement with a high flexion rotating platform bearing
DEVICEPFC Sigma RPAn orthopaedic implant for total knee replacement with a standard flexion rotating platform bearing

Timeline

Start date
2007-11-01
Primary completion
2010-08-01
Completion
2014-08-01
First posted
2008-08-13
Last updated
2016-09-13
Results posted
2014-08-26

Locations

2 sites across 2 countries: Spain, United Kingdom

Source: ClinicalTrials.gov record NCT00733369. Inclusion in this directory is not an endorsement.